Castle Creek Arbitrage’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Castle Creek Arbitrage’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-59,486	Closed	-$1.28K	–	480
2023 Q1	$1.28K	Hold	59,486	–	–	﹤0.01%	453
2022 Q4	$8.12K	Hold	59,486	–	–	﹤0.01%	399
2022 Q3	$10K	Hold	59,486	–	–	﹤0.01%	552
2022 Q2	$9K	Hold	59,486	–	–	﹤0.01%	590
2022 Q1	$46K	Sell	59,486 -400	-0.7%	-$280	﹤0.01%	529
2021 Q4	$37K	Sell	59,886 -56,780	-49%	-$57.6K	﹤0.01%	624
2021 Q3	$107K	Hold	116,666	–	–	0.01%	489
2021 Q2	$167K	Buy	+116,666	New	+$102K	0.01%	481

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Castle Creek Arbitrage's PEARW Position: Q2 2023 in Review

Castle Creek Arbitrage sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 59,486 shares — an estimated $1.28K sold.

Castle Creek Arbitrage first reported a position in PEARW in Q2 2021 and held it in 8 quarters. The position peaked at $167K in Q2 2021. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Castle Creek Arbitrage reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Castle Creek Arbitrage sold 59,486 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $1.28K.
Castle Creek Arbitrage first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2021 and held it in 8 quarters.
Castle Creek Arbitrage's Pear Therapeutics, Inc. Warrant position peaked at $167K in Q2 2021.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Castle Creek Arbitrage's 13F filing for Q2 2023, filed 14 Aug 2023.